New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
19:37 EDTBCRC.R. Bard receives favorable recommendation from FDA panel for Lutonix DCB
C. R. Bard announced that the FDA Circulatory System Devices Advisory Panel provided a unanimous favorable recommendation to FDA for use of the Lutonix Drug Coated Balloon PTA Catheter, or DCB, in the U.S. The Lutonix DCB is currently under review by FDA for improving luminal diameter and reducing the incidence of restenosis for the treatment of obstructive de novo or non-stented restenotic lesions in native femoropopliteal arteries with reference vessel diameters of 4 mm to 6 mm. If approved, it is expected that the Lutonix DCB will be the first and only FDA-approved DCB available in the U.S.
News For BCR From The Last 14 Days
Check below for free stories on BCR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2014
09:45 EDTBCRC.R. Bard downgraded to Underperform from Neutral at BofA/Merrill (pre-open)
July 24, 2014
17:36 EDTBCRC.R. Bard raises FY14 EPS view to $8.25-$8.35 from $8.20-$8.30
Subscribe for More Information
17:34 EDTBCRC.R. Bard sees Q3 EPS $2.07-$2.11, consensus $2.09
Subscribe for More Information
16:25 EDTBCRC.R. Bard reports Q2 adjusted EPS $2.06, consensus $2.01
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use